Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Deplanque, D; Leys, D; Parnetti, L; Schmidt, R; Ferro, J; de Reuck, J; Mas, JL; Gallai, V; SAFE II Investigators.
Secondary prevention of stroke in patients with atrial fibrillation: factors influencing the prescription of oral anticoagulation at discharge.
Cerebrovasc Dis. 2006; 21(5-6):372-379 Doi: 10.1159/000091546
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Co-Autor*innen der Med Uni Graz
Schmidt Reinhold
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
BACKGROUND: Oral anticoagulation (OAC) is the only treatment that has shown a significant benefit to reduce the risk of recurrence in patients with ischemic stroke and nonvalvular atrial fibrillation (NVAF). However, OAC is still underused, even at discharge from neurological centers. The objective of this study was to identify the reasons underlying the prescription of OAC at discharge after an ischemic stroke in patients with NVAF. METHODS: We investigated the reasons why ischemic stroke patients with NVAF were not treated with OAC at discharge from 40 centers located in 5 European countries (Austria, Belgium, France, Italy, and Portugal). RESULTS: Of 320 ischemic stroke survivors at discharge, 186 (58.1%) received OAC, while 260 (81.3%) patients were theoretically eligible according to guidelines and the absence of contraindications. There were significant differences between countries and the logistic regression analysis found being already under OAC before stroke, having no leukoaraiosis, having no potential contraindication, being younger than 75 years, being married and suffering from angina pectoris as independent predictors of being discharged under OAC. CONCLUSION: This study suggests that besides patient-related factors, the prescription of OAC is also significantly influenced by the social environment and national practices.
Find related publications in this database (using NLM MeSH Indexing)
Administration, Oral -
Aged -
Anticoagulants - administration and dosage
Atrial Fibrillation - complications
Brain Ischemia - complications
Cerebrovascular Accident - etiology
Drug Utilization - etiology
Europe - etiology
Female - etiology
Follow-Up Studies - etiology
Humans - etiology
Male - etiology
Middle Aged - etiology
Patient Discharge - etiology
Physician's Practice Patterns - etiology
Prospective Studies - etiology

Find related publications in this database (Keywords)
stroke
atrial fibrillation
secondary prevention
oral anticoagulation
antiplatelet drugs
© Med Uni Graz Impressum